Researchers
Belić, Jelena
Type
Issue Date | Title | Author(s) | Type | М-cat. |
---|---|---|---|---|
2019 | Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection | Ulz P.; Perakis S.; Zhou Q.; Moser T.; Belic J. ![]() ![]()
Petru E.; White B.; Roberts C.E.S.; John J.S.; Schimek M.G.; Geigl J.B.; Bauernhofer T.; Sill H.; Bock C.; Heitzer E.; Speicher M.R.;
| Article | 21aM21a |
2018 | Analysis of circulating tumor DNA reveals genomic alterations in metastatic prostate cancer patients treated with abiraterone acetate plus prednisone or enzalutamide | Belic J. ![]() ![]()
Geigl J.B.; Smirnov D.; Heitzer E.; Mitchell G.; Speicher M.A.;
| Conference Paper | Mp. category will be shown later |
2018 | Genomic alterations in plasma DNA from patients with metastasized prostate cancer receiving abiraterone or enzalutamide | Belic J. ![]() ![]()
Geigl J.B.; Smirnov D.; Heitzer E.; Gross M.; Speicher M.R.;
| Article | 21M21 |
2017 | Characterisation and treatment of patients with castration-resistant metastatic prostate cancer (mCRPC) developing neuroendocrine clonal divergence (NCD): A case series | Bauernhofer T.; Belic J. ![]() ![]() | Conference Paper | Mp. category will be shown later |